Roger Daly
Roger Daly
Dept of Biochemistry and Molecular Biology, Monash University
Verified email at
Cited by
Cited by
Genomic analyses identify molecular subtypes of pancreatic cancer
P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ...
Nature 531 (7592), 47-52, 2016
Genomic analyses identify molecular subtypes of pancreatic cancer.
H Australian Pancreatic Cancer Genome Initiative*, Munzy DM, Fisher WE ...
Nature 531 (7592), 45-52, 2016
Whole genomes redefine the mutational landscape of pancreatic cancer
N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ...
Nature 518 (7540), 495-501, 2015
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
EJ Lowenstein, RJ Daly, AG Batzer, W Li, B Margolis, R Lammers, ...
Cell 70 (3), 431-442, 1992
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
M Rozakis-Adcock, J McGlade, G Mbamalu, G Pelicci, R Daly, W Li, ...
Nature 360 (6405), 689-692, 1992
Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling
N Li, A Batzer, R Daly, V Yajnik, E Skolnik, P Chardin, D Bar-Sagi, ...
Nature 363 (6424), 85-88, 1993
The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.
EY Skolnik, CH Lee, A Batzer, LM Vicentini, M Zhou, R Daly, MJ Myers Jr, ...
The EMBO journal 12 (5), 1929-1936, 1993
Dual-specificity phosphatases: critical regulators with diverse cellular targets
KI Patterson, T Brummer, PM O'brien, RJ Daly
Biochemical Journal 418 (3), 475-489, 2009
iFeature: a Python package and web server for features extraction and selection from protein and peptide sequences
Z Chen, P Zhao, F Li, A Leier, TT Marquez-Lago, Y Wang, GI Webb, ...
Bioinformatics 34 (14), 2499-2502, 2018
PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality
E López‐Knowles, SA O'Toole, CM McNeil, EKA Millar, MR Qiu, P Crea, ...
International journal of cancer 126 (5), 1121-1131, 2010
SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high‐affinity binding site for SH2 domains of phospholipase C gamma.
D Rotin, B Margolis, M Mohammadi, RJ Daly, G Daum, N Li, EH Fischer, ...
The EMBO journal 11 (2), 559-567, 1992
FAK signaling in human cancer as a target for therapeutics
BY Lee, P Timpson, LG Horvath, RJ Daly
Pharmacology & therapeutics 146, 132-149, 2015
Cortactin signalling and dynamic actin networks
RJ Daly
Biochemical Journal 382 (1), 13-25, 2004
Cyclin D1, EMS1 and 11q13 amplification in breast cancer
CJ Ormandy, EA Musgrove, R Hui, RJ Daly, RL Sutherland
Breast cancer research and treatment 78, 323-335, 2003
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ...
Nature 486 (7402), 266-270, 2012
Cell cycle control in breast cancer cells
CE Caldon, RJ Daly, RL Sutherland, EA Musgrove
Journal of cellular biochemistry 97 (2), 261-274, 2006
Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
PW Janes, RJ Daly, RL Sutherland
Oncogene 9 (12), 3601-3608, 1994
Identification of Tek/Tie2 binding partners: binding to a multifunctional docking site mediates cell survival and migration
N Jones, Z Master, J Jones, D Bouchard, Y Gunji, H Sasaki, R Daly, ...
Journal of Biological Chemistry 274 (43), 30896-30905, 1999
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Y Zheng, C Zhang, DR Croucher, MA Soliman, N St-Denis, A Pasculescu, ...
Nature 499 (7457), 166-171, 2013
The system can't perform the operation now. Try again later.
Articles 1–20